How can we improve compliance in schizophrenia ? Satellite Symposium. Melbourne (AUS), 1996/06/24.
Efforts to improve compliance and facilitate other aspects of relapse-prevention strategies can have a profound impact on the lives of millions of people around the world as well as conserving precious health-care dollars.
Simultaneous efforts to educate patients and families on the nature of the disease, its course and optimum treatment, together with efforts to educate physicians and other health-care professionals on the indications, benefits and risks of long-term treatment, are critical for improving the current state of affairs.
In addition, it is imperative to educate the public at large and particularly those health-care administrators and public servants who control or influence the allocation of the resources needed.
Mots-clés Pascal : Education santé, Programme thérapeutique, Schizophrénie, Psychose, Observance médicamenteuse, Toxicité, Chimiothérapie, Efficacité traitement, Psychotrope, Neuroleptique, Homme
Mots-clés Pascal anglais : Health education, Therapeutic schedule, Schizophrenia, Psychosis, Drug compliance, Toxicity, Chemotherapy, Treatment efficiency, Psychotropic, Neuroleptic, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0339991
Code Inist : 002B02B03. Création : 12/09/1997.